vs
Side-by-side financial comparison of DYNEX CAPITAL INC (DX) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.
MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $43.5M, roughly 1.1× DYNEX CAPITAL INC). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs -11.8%). Over the past eight quarters, DYNEX CAPITAL INC's revenue compounded faster (75.8% CAGR vs -11.9%).
Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.
Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.
DX vs MRVI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.5M | $49.9M |
| Net Profit | — | $-35.7M |
| Gross Margin | — | 25.8% |
| Operating Margin | — | -117.9% |
| Net Margin | — | -71.6% |
| Revenue YoY | 531.3% | -11.8% |
| Net Profit YoY | — | -37.7% |
| EPS (diluted) | $1.59 | $-0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.5M | $49.9M | ||
| Q3 25 | $30.6M | $41.6M | ||
| Q2 25 | $23.1M | $47.4M | ||
| Q1 25 | $17.1M | $46.9M | ||
| Q4 24 | — | $56.6M | ||
| Q3 24 | — | $69.0M | ||
| Q2 24 | — | $69.4M | ||
| Q1 24 | $-3.2M | $64.2M |
| Q4 25 | — | $-35.7M | ||
| Q3 25 | $150.4M | $-25.6M | ||
| Q2 25 | $-13.6M | $-39.6M | ||
| Q1 25 | $-3.1M | $-29.9M | ||
| Q4 24 | — | $-25.9M | ||
| Q3 24 | — | $-97.1M | ||
| Q2 24 | — | $-9.8M | ||
| Q1 24 | $40.1M | $-12.1M |
| Q4 25 | — | 25.8% | ||
| Q3 25 | — | 13.6% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 16.5% | ||
| Q4 24 | — | 34.3% | ||
| Q3 24 | — | 46.7% | ||
| Q2 24 | — | 44.4% | ||
| Q1 24 | — | 40.3% |
| Q4 25 | — | -117.9% | ||
| Q3 25 | — | -98.6% | ||
| Q2 25 | — | -139.8% | ||
| Q1 25 | — | -104.9% | ||
| Q4 24 | — | -66.7% | ||
| Q3 24 | — | -239.9% | ||
| Q2 24 | — | -19.4% | ||
| Q1 24 | — | -29.4% |
| Q4 25 | — | -71.6% | ||
| Q3 25 | 491.3% | -61.4% | ||
| Q2 25 | -58.8% | -83.5% | ||
| Q1 25 | -18.0% | -63.9% | ||
| Q4 24 | — | -45.8% | ||
| Q3 24 | — | -140.6% | ||
| Q2 24 | — | -14.1% | ||
| Q1 24 | -1256.8% | -18.8% |
| Q4 25 | $1.59 | $-0.24 | ||
| Q3 25 | $1.08 | $-0.18 | ||
| Q2 25 | $-0.14 | $-0.27 | ||
| Q1 25 | $-0.06 | $-0.21 | ||
| Q4 24 | — | $-0.21 | ||
| Q3 24 | — | $-0.68 | ||
| Q2 24 | — | $-0.07 | ||
| Q1 24 | $0.64 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $531.0M | $216.9M |
| Total DebtLower is stronger | — | $291.8M |
| Stockholders' EquityBook value | $2.5B | $212.4M |
| Total Assets | $17.3B | $770.6M |
| Debt / EquityLower = less leverage | — | 1.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $531.0M | $216.9M | ||
| Q3 25 | $491.0M | $243.6M | ||
| Q2 25 | $387.5M | $269.9M | ||
| Q1 25 | $327.4M | $285.1M | ||
| Q4 24 | — | $322.4M | ||
| Q3 24 | — | $578.2M | ||
| Q2 24 | — | $573.2M | ||
| Q1 24 | $295.7M | $561.7M |
| Q4 25 | — | $291.8M | ||
| Q3 25 | — | $292.8M | ||
| Q2 25 | — | $293.9M | ||
| Q1 25 | — | $294.9M | ||
| Q4 24 | — | $295.9M | ||
| Q3 24 | — | $521.7M | ||
| Q2 24 | — | $522.5M | ||
| Q1 24 | — | $523.3M |
| Q4 25 | $2.5B | $212.4M | ||
| Q3 25 | $2.0B | $245.4M | ||
| Q2 25 | $1.6B | $265.9M | ||
| Q1 25 | $1.4B | $300.6M | ||
| Q4 24 | — | $325.3M | ||
| Q3 24 | — | $344.9M | ||
| Q2 24 | — | $434.7M | ||
| Q1 24 | $958.5M | $410.7M |
| Q4 25 | $17.3B | $770.6M | ||
| Q3 25 | $14.2B | $849.2M | ||
| Q2 25 | $11.3B | $897.0M | ||
| Q1 25 | $9.0B | $959.8M | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | $6.3B | $1.4B |
| Q4 25 | — | 1.37× | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | 1.11× | ||
| Q1 25 | — | 0.98× | ||
| Q4 24 | — | 0.91× | ||
| Q3 24 | — | 1.51× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 1.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $120.8M | $-22.8M |
| Free Cash FlowOCF − Capex | — | $-24.9M |
| FCF MarginFCF / Revenue | — | -49.9% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-70.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.8M | $-22.8M | ||
| Q3 25 | $68.3M | $-15.2M | ||
| Q2 25 | $31.9M | $-10.3M | ||
| Q1 25 | $6.4M | $-9.4M | ||
| Q4 24 | — | $-14.6M | ||
| Q3 24 | — | $13.1M | ||
| Q2 24 | — | $17.4M | ||
| Q1 24 | $-17.1M | $-8.5M |
| Q4 25 | — | $-24.9M | ||
| Q3 25 | — | $-18.1M | ||
| Q2 25 | — | $-13.1M | ||
| Q1 25 | — | $-14.6M | ||
| Q4 24 | — | $-20.5M | ||
| Q3 24 | — | $4.5M | ||
| Q2 24 | — | $7.9M | ||
| Q1 24 | — | $-14.1M |
| Q4 25 | — | -49.9% | ||
| Q3 25 | — | -43.4% | ||
| Q2 25 | — | -27.7% | ||
| Q1 25 | — | -31.2% | ||
| Q4 24 | — | -36.2% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | 11.4% | ||
| Q1 24 | — | -22.0% |
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 11.2% | ||
| Q4 24 | — | 10.3% | ||
| Q3 24 | — | 12.4% | ||
| Q2 24 | — | 13.8% | ||
| Q1 24 | — | 8.8% |
| Q4 25 | — | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.43× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DX
Segment breakdown not available.
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
